| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |